China Endoscope Market Overview

With the continuous development of treatment technology in China, minimally invasive treatment technology has become a new direction on behalf of medical development, and endoscopic minimally invasive treatment is clinical medicine and the rapid development in recent years of optical and mechanical information science, materials science and biotechnology The organic combination of high-tech disciplines, the use of endoscopic minimally invasive surgery with its advantages of less trauma, shorter operative time, faster postoperative recovery, etc., has been favored by both doctors and patients. It has become an indispensable tool for the diagnosis and treatment of system diseases such as digestion, respiration, urology, and otolaryngology.

The development of endoscopic technology in China has been a history of more than half a century. In 2010, the total industrial output value of the endoscope industry in China exceeded RMB 4 billion, an increase of approximately 25% over the same period of last year. The total profit of the industry was nearly 1.4 billion, an increase of approximately 6% year-on-year. Although the level of endoscopic diagnosis and treatment in China has been a certain development, but in the equipment market, about 70% of the domestic endoscope market has been monopolized by foreign brands, from the application point of view, foreign high-end brands are mainly used in gastroscopy, fallopian tubes , urethra, enteroscopy, bronchial and other professional medical care. In the treatment of ear, nose and throat, domestic hospitals, outpatients, etc. mainly use domestic products with higher cost performance, such as three-dimensional, medical light, Cheng Yun and other brands.

Foreign brands from the product, technology and services have an absolute advantage, including Olympus (22%), Pentax (14%), Fujinon (15%), Carl Stouts, WOLF (11%) and history Grams (8%) of the six major brands occupy a dominant position. Although domestic brands have an advantage in terms of price, the technical level is still a weakness, and the ability to develop sales channels cannot match that of foreign brands. Therefore, the market share is very low.

In the near future, endoscopic technology will become the mainstream of clinical minimally invasive techniques. For example, capsule endoscopes will be developed in the direction of diversification, intelligence, and characteristics. Traditional endoscopes will also be combined with new technologies. Japan, the United States, and European companies have a large number of core patented technologies. With the continuous development of medical endoscope technology, they will continue to use their current patent advantages to continuously consolidate their monopoly on technology.

Domestic enterprises should give full play to their own technical characteristics, increase cooperation with universities and research institutes, and use their comprehensive R&D capabilities to rapidly break through technical difficulties and master key technologies. In the capsule endoscope, disposable endoscope and other aspects to form their own technical advantages for the development of our endoscope equipment technology reserves. At the same time, the joint medical institution continuously improves and practices the technology through its clinical resources, and quickly realizes industrialization, thereby breaking the absolute leading position of foreign companies in the field of endoscopy, forming their own core technologies and improving their competitiveness.